Metraipolis › archive › dc_6b26014ee59e
Computational repurposing of approved drugs targeting KRAS G12D and EGFR for colorectal cancer therapy — Europe PMC PMID:41604371
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41604371
- DOI
- 10.1371/journal.pone.0338123
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T11:32:02.294Z
- SHA-256 of the archived text
cb0e18e073a6b0ad77288cba9efd0e4a064a94b23962771a105d3dca7ab392e3- Stable URL of this page
https://metraipolis.com/documento/dc_6b26014ee59e
How to cite
Computational repurposing of approved drugs targeting KRAS G12D and EGFR for colorectal cancer therapy — Europe PMC PMID:41604371 — Europe PMC (en), https://europepmc.org/article/MED/41604371 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6b26014ee59e (Metraipolis archive dc_6b26014ee59e, sha256 cb0e18e073a6b0ad77288cba9efd0e4a064a94b23962771a105d3dca7ab392e3)
BibTeX
@misc{dc6b26014ee59e,
title = {Computational repurposing of approved drugs targeting KRAS G12D and EGFR for colorectal cancer therapy — Europe PMC PMID:41604371},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41604371},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6b26014ee59e; sha256 cb0e18e073a6b0ad77288cba9efd0e4a064a94b23962771a105d3dca7ab392e3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41604371. Agents can read the archived copy with the MCP tool read_document.